May 27, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Gilead Sciences, Inc. (NASDAQ:GILD) shares over potential securities laws violations by Gilead Sciences and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Gilead Sciences, Inc. (NASDAQ:GILD) concerning whether a series of statements by Gilead Sciences, regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Gilead Sciences, Inc. reported that its annual Total Revenue rose from $24.89 billion in 2014 to over $32.63 billion in 2015 and that its Net Income increased from over $12.1 billion in 2014 to over $18.1 billion in 2015.

On May 27, 2016,it was reported that Gilead Sciences, Inc had received a subpoena from the U.S. Attorney for the District of Massachusetts, initially disclosed in the Company's 10-Q for the quarter ended March 31, 2016, seeking documents related to the Company's relationship with certain nonprofits that provide financial assistance to patients.
Shares of Gilead Sciences, Inc. (NASDAQ:GILD) closed on May 27, 2016, aty $85.82 per share.